![Pierre Jacquet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pierre Jacquet
Direktor/Vorstandsmitglied bei MEREO BIOPHARMA GROUP PLC
Vermögen: 1 Mio $ am 31.05.2024
Profil
Pierre Jacquet is currently the Vice Chairman & MD-Global Healthcare at The Lek, Vice Chairman & MD-Healthcare Practice at L.E.K.
Consulting LLC, and Non-Executive Director at Mereo BioPharma Group Plc.
Previously, he held positions as Director at Osprey Pharmaceuticals USA, Inc., Independent Director at EXACT Sciences Corp., Head-Business Development at Genzyme Corp., Manager at Arthur D.
Little, Inc., and Advisor at Transfer Technologies Commercialisation Capital.
He obtained a doctorate from the University of Liege in 1996 and an MBA from the University of Virginia Darden School of Business in 1998.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
08.06.2023 | 23 576 ( 0,01% ) | 1 Mio $ | 31.05.2024 | |
31.03.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Pierre Jacquet
Unternehmen | Position | Beginn |
---|---|---|
MEREO BIOPHARMA GROUP PLC | Direktor/Vorstandsmitglied | 20.09.2021 |
The Lek/Alcar Consulting Group, Inc.
![]() The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
L.E.K. Consulting LLC
![]() L.E.K. Consulting LLC Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting LLC operates as a management consulting firm. It offers disruption management, post-merger integration, and marketing and sales services. The company was founded by James Lawrence, Iain Evans and Richard Koch in 1983 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.01.2001 |
Ehemalige bekannte Positionen von Pierre Jacquet
Unternehmen | Position | Ende |
---|---|---|
EXACT SCIENCES CORPORATION | Direktor/Vorstandsmitglied | 13.06.2024 |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2000 |
Osprey Pharmaceuticals USA, Inc.
![]() Osprey Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Osprey Pharmaceuticals USA, Inc. develops protein therapeutics. The firm provides products for the treatment of inflammatory and autoimmune conditions. The company was founded in 2008 and is headquartered in San Francisco, CA | Direktor/Vorstandsmitglied | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Transfer Technologies Commercialisation Capital
![]() Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² (Transfer Technologies Commercialisation Capital) is a Montréal-based venture capital partnership. They were founded in 1997. | Corporate Officer/Principal | - |
Ausbildung von Pierre Jacquet
University of Virginia Darden School of Business | Masters Business Admin |
University of Liege | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EXACT SCIENCES CORPORATION | Health Technology |
MEREO BIOPHARMA GROUP PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
Transfer Technologies Commercialisation Capital
![]() Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² (Transfer Technologies Commercialisation Capital) is a Montréal-based venture capital partnership. They were founded in 1997. | Finance |
The Lek/Alcar Consulting Group, Inc.
![]() The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Commercial Services |
L.E.K. Consulting LLC
![]() L.E.K. Consulting LLC Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting LLC operates as a management consulting firm. It offers disruption management, post-merger integration, and marketing and sales services. The company was founded by James Lawrence, Iain Evans and Richard Koch in 1983 and is headquartered in Boston, MA. | Commercial Services |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Arthur D. Little, Inc.
![]() Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
Osprey Pharmaceuticals USA, Inc.
![]() Osprey Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Osprey Pharmaceuticals USA, Inc. develops protein therapeutics. The firm provides products for the treatment of inflammatory and autoimmune conditions. The company was founded in 2008 and is headquartered in San Francisco, CA | Health Technology |